David Hesk

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Filter by Publication Topic

Search Results

Designer drugs: Chemistry, analysis, regulation, toxicology, epidemiology and legislation of new psychoactive substances

Rethinking polyester polyurethanes: Algae-based renewable, sustainable, biodegradable, and recyclable materials

Synthesis and pharmacological validation of a novel radioligand for the orphan GPR88 receptor

Identification of a potent human trace amine-associated receptor 1 antagonist

Metallaphotoredox aryl and alkyl radiomethylation for PET ligand discovery

New methodologies for labelling with hydrogen isotopes

Hydrogen isotope exchange labelling: A brief update

Base metal-catalyzed hydrogen isotope exchange

Synthesis of [H-3] and [C-14]genipin

Highlights of C (sp2 )-H hydrogen isotope exchange reactions

Deuterated active pharmaceutical ingredients: A science based proposal for synthesis, analysis, and control. Part 1: Framing the problem

Iridium-catalysed hydrogen isotope exchange of amino acid and peptide molecules

Ni(I)-X Complexes Bearing a Bulky α-Diimine Ligand: Synthesis, structure, and superior catalytic performance in the hydrogen isotope exchange in pharmaceuticals

Site-selective nickel-catalyzed hydrogen isotope exchange in h-heterocycles and its application to the tritiation of pharmaceuticals

Synthesis of 3 H, 13 C 2 , 2 H 4 14 C-SCH 430765 and 35 S-SCH 500946, potent and selective inhibitors of the NPY 5 receptor.

Synthesis of 3H, 13C2, 2H414C‐SCH 430765 and 35S‐SCH 500946, potent and selective inhibitors of the NPY5 receptor

S-34: A new opportunity for the efficient synthesis of stable isotope labeled compounds

34S: A new opportunity for the efficient synthesis of stable isotope labeled compounds

A general strategy for site-selective incorporation of deuterium and tritium into pyridines, diazines, and pharmaceuticals

Photoredox-catalyzed deuteration and tritiation of pharmaceutical compounds